How is precision diagnostics transforming the management of renal cell carcinoma (RCC)?
In this EMUC TV interview, our UROONCO RCC associate editor Dr. Eduard Roussel speaks with Dr. João Lobo about the rapidly evolving landscape of RCC diagnostics. Learn how molecular classification, liquid biopsy technologies, AI-assisted pathology, and improved integration between clinicians and pathologists may help refine diagnosis, prognosis, and treatment selection for patients with kidney cancer.